Product Code: GDHCER055
Major depressive disorder (MDD), also known as clinical depression or major depression, is widely recognized as one of the most common mental disorders in the world. MDD is a type of mood disorder characterized by persistent feelings of sadness, anger, loss, or frustration that can last from days to months and alternates with episodes of wellness. MDD is a highly debilitating condition that is associated with substantial morbidity and an enormous social and economic burden. The condition affects the thoughts, feelings, behavior, and physical health of an individual, leading to a range of psychological, physical, and social problems.
GlobalData epidemiologists forecast that the total prevalent cases of MDD in the 8MM will grow by 4.0% over the next decade, from 31,798,832 total prevalent cases in 2013 to 33,083,108 total prevalent cases in 2023. GlobalData epidemiologists attribute the growth in the total prevalent cases of MDD in the 8MM to changing population demographics in the respective markets, rather than to an actual increase in the prevalence of MDD in these markets.
GlobalData's epidemiological forecast for the total prevalent cases of MDD in the 8MM is supported by epidemiologic data from country-specific studies that are nationally representative of the entire population in these markets. GlobalData's epidemiological analysis included the most recently published nationally-representative studies in the 8MM that provided the total prevalence of MDD using the DSM-IV diagnostic criteria and the CIDI version 3.0, which facilitates for a meaningful comparison of the forecast total prevalent cases of MDD in the 8MM. Additionally, the use of the total prevalence to forecast the total prevalent cases of MDD in the 8MM further strengthens GlobalData's epidemiological analysis, because the total prevalence reflects the true burden of a highly undiagnosed disease like MDD.
- The Major Depressive Disorder (MDD) EpiCast Report provides an overview of the risk factors and the global and historical trends of MDD in the 8MM (US, France, Germany, Italy, Spain, UK, Japan, and Australia). It includes a 10-year epidemiological forecast for the total prevalent cases of MDD segmented by age (20 years and older) and sex.
- The MDD epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.
Reasons to buy
- Develop business strategies by understanding the trends shaping and driving the global MDD market.
- Quantify patient populations in the global MDD market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for MDD therapeutics in each of the markets covered.
Table of Contents
1. Table of Contents
- 1.1. List of Tables
- 1.2. List of Figures
- 3.1. Disease Background
- 3.2. Risk Factors and Comorbidities
- 3.2.1. A Family History of MDD Increases the Risk for MDD by Almost 14 Times
- 3.2.2. Substance Abuse and Lifetime Anxiety Disorders are Highly Prevalent in MDD Patients
- 3.3. Global and Historical Trends
- 3.4. Forecast Methodology
- 3.4.1. Sources Used
- 3.4.2. Forecast Assumptions and Methods
- 3.4.3. Sources Not Used
- 3.5. Epidemiological Forecast for MDD (2013-2023)
- 3.5.1. Total Prevalent Cases of MDD
- 3.5.2. Age-Specific Total Prevalent Cases of MDD
- 3.5.3. Sex-Specific Total Prevalent Cases of MDD
- 3.5.4. Age-Standardized Total Prevalence of MDD
- 3.6. Discussion
- 3.6.1. Epidemiological Forecast Insight
- 3.6.2. Limitations of the Analysis
- 3.6.3. Strengths of the Analysis
- 4.1. Bibliography
- 4.2. About the Authors
- 4.2.1. Epidemiologists
- 4.2.2. Reviewers
- 4.2.3. Global Director of Epidemiology and Health Policy
- 4.2.4. Global Head of Healthcare
- 4.3. About GlobalData
- 4.4. About EpiCast
- 4.5. Disclaimer
List of Tables
- Table 1: DSM-IV Diagnostic Criteria for MDD
- Table 2: Risk Factors and Comorbidities for MDD
- Table 3: Prevalence of the Most Frequent Psychiatric Comorbidities in Individuals With and Without MDD
- Table 4: 8MM, Total Prevalence (%) of MDD According to the DSM-IV Criteria
- Table 5: 8MM, Total Prevalence (%) of MDD According to the DSM-III Criteria
- Table 6: 8MM, Sources of the MDD Prevalence Data Used to Forecast the Total Prevalent Cases of MDD
- Table 7: 8MM, Sources Excluded from the Forecast for the Total Prevalent Cases of MDD
- Table 8: 8MM, Total Prevalent Cases of MDD, Ages ≥20 Years, Both Sexes, N, 2013-2023
- Table 9: 8MM, Total Prevalent Cases of MDD, by Age, Both Sexes, N (Row %), 2013
- Table 10: 8MM, Total Prevalent Cases of MDD, by Sex, Ages ≥20 Years, N (Row %), 2013
List of Figures
- Figure 1: 8MM, Total Prevalent Cases of MDD, Ages ≥20 Years, Both Sexes, N, 2013-2023
- Figure 2: 8MM, Total Prevalent Cases of MDD, by Age, Both Sexes, N, 2013
- Figure 3: 8MM, Total Prevalent Cases of MDD, by Sex, Ages ≥20 Years, N, 2013
- Figure 4: 8MM, Age-Standardized Total Prevalence (%) of MDD, by Sex, Ages ≥20 Years, 2013